Albuminuria Reduction Accounts for Much of Finerenone Effect on CKD

MONDAY, Dec. 4, 2023 -- For patients with chronic kidney disease (CKD) and type 2 diabetes, early albuminuria reduction accounts for a large proportion of the treatment effect of finerenone against CKD progression, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news